Print

MS Drug May One Day Treat Colorectal Cancer, Virginia Commonwealth University Study  
1/10/2013 7:17:21 AM

After uncovering a mechanism that promotes chronic intestinal inflammation and the development of colorectal cancer, scientists from Virginia Commonwealth University Massey Cancer Center have found that fingolimod, a drug currently approved for the treatment of multiple sclerosis, could potentially eliminate or reduce the progression of colitis-associated cancer (CAC).
//-->